These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24363332)

  • 1. The pertussis problem.
    Plotkin SA
    Clin Infect Dis; 2014 Mar; 58(6):830-3. PubMed ID: 24363332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis: pertussis control strategies and the options for improving current vaccines.
    Plotkin SA
    Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.
    Sutherland JN; Chang C; Yoder SM; Rock MT; Maynard JA
    Clin Vaccine Immunol; 2011 Jun; 18(6):954-62. PubMed ID: 21508166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic response and antibody-titer decay in adults with pertussis.
    Heininger U; Cherry JD; Stehr K
    Clin Infect Dis; 2004 Feb; 38(4):591-4. PubMed ID: 14765356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
    Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
    Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the laboratory approaches to the detection of antibody and cell-mediated immunity to pertussis disease and vaccine.
    Edwards KM
    Expert Rev Vaccines; 2014 Oct; 13(10):1183-90. PubMed ID: 25096058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.
    Allen AC; Mills KH
    Expert Rev Vaccines; 2014 Oct; 13(10):1253-64. PubMed ID: 25017925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acellular pertussis vaccine].
    Wiedermann G; Ambrosch F; Vanura H
    Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to pertussis vaccines and disease.
    Edwards KM; Berbers GA
    J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of postvaccinal response in children past pertussis].
    Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K
    Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.